Skip to main content
Watch Insiders
HUMAHealthcare

Humacyte Inc (HUMA) Insider Trading

In the last 90 days, 1 Humacyte Inc (HUMA) insider reported 3 open-market purchases totaling $30,370 and no sales. The most recent open-market purchase was reported on Sep 14, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$30,370
Corporate buyers
1
Latest transaction
Sep 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 14, 2026Keith Anthony JonesDirectorOpen Market Purchase10,000$0.56$5,620
Aug 20, 2026Keith Anthony JonesDirectorOpen Market Purchase10,000$0.69$6,930
Aug 17, 2026Keith Anthony JonesDirectorOpen Market Purchase30,000$0.59$17,820
May 19, 2026Kathleen SebeliusDirectorOpen Market Purchase56,818$0.88$50,000
May 18, 2026Shamik J ParikhChief Medical OfficerSale45,887$0.90$41,147
May 18, 2026Dale A. SanderCFO and Chief Corp. Dev. OffSale45,887$0.90$41,147
May 18, 2026Michael T. ConstantinoDirectorOpen Market Purchase11,000$0.89$9,840

Common questions

HUMA insider trading FAQ

Are HUMA insiders buying or selling?
Over the last 90 days, HUMA insiders were net buyers, reporting $30,370 of open-market purchases and $0.00 of sales.
When was the last HUMA insider purchase?
The most recent open-market purchase of Humacyte Inc stock by an insider was reported on Sep 14, 2026, one of 3 purchases in the last 90 days.
Where does HUMA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Humacyte Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.